Advances in understanding the pathogenesis of primary familial and congenital polycythaemia

British Journal of Haematology

Volumn 148, Issue 6, 2010, Pages 844-852

  Huang, Lily J ^a   Shen, Yu Min ^b   Bulut, Gamze B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Endocytosis; Erythrocytosis; Erythropoietin receptor; Primary familial and congenital polycythemia; Receptor down regulation

Indexed keywords

ERYTHROPOIETIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; PROTEIN SUBUNIT; UBIQUITIN;

CONGENITAL MALFORMATION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DOWN REGULATION; ERYTHROCYTOSIS; FAMILIAL DISEASE; GENE MUTATION; HUMAN; POLYCYTHEMIA; PRIMARY FAMILIAL AND CONGENITAL POLYCYTHAEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; GENETICS; MUTATION; PHYSIOLOGY;

DOWN-REGULATION; HUMANS; MUTATION; POLYCYTHEMIA; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION;

EID: 77649200801     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08069.x     Document Type: Review

References (101)

1. Al-Sheikh, M., Moradkhani, K., Lopez, M., Wajcman, H. Prehu, C. (2008a) Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Blood Cells, Molecules, and Diseases, 40, 160 165.
2. Al-Sheikh, M., Mazurier, E., Gardie, B., Casadevall, N., Galacteros, F., Goossens, M., Wajcman, H., Prehu, C. Ugo, V. (2008b) A study of 36 unrelated cases with pure erythrocytosis revealed three new mutations in the erythropoietin receptor gene. Haematologica, 93, 1072 1075.
3. Arai, A., Kanda, E., Nosaka, Y., Miyasaka, N. Miura, O. (2001) CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling. Journal of Biological Chemistry, 276, 33282 33290.
4. Arcasoy, M.O. Karayal, A.F. (2005) Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain. Biochimica et Biophysica Acta, 1740, 17 28.
5. Arcasoy, M.O., Degar, B.A., Harris, K.W. Forget, B.G. (1997) Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood, 89, 4628 4635.
6. Arcasoy, M.O., Harris, K.W. Forget, B.G. (1999) A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Experimental Hematology, 27, 63 74.
7. Arcasoy, M.O., Karayal, A.F., Segal, H.M., Sinning, J.G. Forget, B.G. (2002) A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis. Blood, 99, 3066 3069.
8. Barber, D.L., Corless, C.N., Xia, K., Roberts, T.M. D'Andrea, A.D. (1997) Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells. Blood, 89, 55 64.
9. Beckman, D.L., Lin, L.L., Quinones, M.E. Longmore, G.D. (1999) Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. Blood, 94, 2667 2675.
10. Bourantas, L.K., Chatzikyriakidou, A., Dasoula, A., Syrrou, M., Bournatas, K.L. Georgiou, I. (2006) Absence of mutations of the EPO-receptor gene in Greek patients with familial polycythemia. European Journal of Haematology, 76, 537 538.
11. Bouscary, D., Pene, F., Claessens, Y.E., Muller, O., Chretien, S., Fontenay-Roupie, M., Gisselbrecht, S., Mayeux, P. Lacombe, C. (2003) Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood, 101, 3436 3443.
12. Cario, H. (2005) Childhood polycythemias/erythrocytoses: classification, diagnosis, clinical presentation, and treatment. Annals of Hematology, 84, 137 145.
13. Cartier, P., Labie, D., Leroux, J.P., Najman, A. Demaugre, F. (1972) [Familial diphosphoglycerate mutase deficiency: hematological and biochemical study]. Nouvelle Revue Francaise D Hematologie, 12, 269 287.
14. de la Chapelle, A., Sistonen, P., Lehvaslaiho, H., Ikkala, E. Juvonen, E. (1993a) Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet, 341, 82 84.
15. de la Chapelle, A., Traskelin, A.L. Juvonen, E. (1993b) Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proceedings of the National Academy of Sciences of the United States of America, 90, 4495 4499.
16. Charache, S., Weatherall, D.J. Clegg, J.B. (1966) Polycythemia associated with a hemoglobinopathy. Journal of Clinical Investigation, 45, 813 822.
17. Chin, H., Arai, A., Wakao, H., Kamiyama, R., Miyasaka, N. Miura, O. (1998) Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood, 91, 3734 3745.
18. Chu, X., Cheung, J.Y., Barber, D.L., Birnbaumer, L., Rothblum, L.I., Conrad, K., Abrasonis, V., Chan, Y.M., Stahl, R., Carey, D.J. Miller, B.A. (2002) Erythropoietin modulates calcium influx through TRPC2. Journal of Biological Chemistry, 277, 34375 34382.
19. Constantinescu, S.N., Ghaffari, S. Lodish, H.F. (1999) The erythropoietin receptor: structure, activation and intracellular signal transduction. Trends in Endocrinology and Metabolism, 10, 18 23.
20. Davis, C.A., Crowley, L.J. Barber, M.J. (2004) Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*. Archives of Biochemistry and Biophysics, 431, 233 244.
21. Divoky, V., Liu, Z., Ryan, T.M., Prchal, J.F., Townes, T.M. Prchal, J.T. (2001) Mouse model of congenital polycythemia: homologous replacement of murine gene by mutant human erythropoietin receptor gene. Proceedings of the National Academy of Sciences of the United States of America, 98, 986 991.
22. Emanuel, P.D., Eaves, C.J., Broudy, V.C., Papayannopoulou, T., Moore, M.R., D'Andrea, A.D., Prchal, J.F., Eaves, A.C. Prchal, J.T. (1992) Familial and congenital polycythemia in three unrelated families. Blood, 79, 3019 3030.
23. Endo, T.A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S. Yoshimura, A. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921 924.
24. Fermo, E., Bianchi, P., Vercellati, C., Marcello, A.P., Garatti, M., Marangoni, O., Barcellini, W. Zanella, A. (2008) Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene. Blood Cells, Molecules, and Diseases, 41, 50 55.
25. Furukawa, T., Narita, M., Sakaue, M., Otsuka, T., Kuroha, T., Masuko, M., Azegami, T., Kishi, K., Takahashi, M., Utsumi, J., Koike, T. Aizawa, Y. (1997) Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor. British Journal of Haematology, 99, 222 227.
26. Galacteros, F., Rosa, R., Prehu, M.O., Najean, Y. Calvin, M.C. (1984) [Diphosphoglyceromutase deficiency: new cases associated with erythrocytosis]. Nouvelle Revue Francaise D Hematologie, 26, 69 74.
27. Gillo, B., Ma, Y.S. Marks, A.R. (1993) Calcium influx in induced differentiation of murine erythroleukemia cells. Blood, 81, 783 792.
28. Gobert, S., Chretien, S., Gouilleux, F., Muller, O., Pallard, C., Dusanter-Fourt, I., Groner, B., Lacombe, C., Gisselbrecht, S. Mayeux, P. (1996) Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO Journal, 15, 2434 2441.
29. Gonzalez Fernandez, F.A., Villegas, A., Ropero, P., Carreno, M.D., Anguita, E., Polo, M., Pascual, A. Henandez, A. (2009) Haemoglobinopathies with high oxygen affinity. Experience of Erythropathology Cooperative Spanish Group. Annals of Hematology, 88, 235 238.
30. Gordeuk, V.R., Stockton, D.W. Prchal, J.T. (2005) Congenital polycythemias/erythrocytoses. Haematologica, 90, 109 116.
31. Harder, K.W., Quilici, C., Naik, E., Inglese, M., Kountouri, N., Turner, A., Zlatic, K., Tarlinton, D.M. Hibbs, M.L. (2004) Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood, 104, 3901 3910.
32. Helgason, C.D., Damen, J.E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S.M., Borowski, A., Jirik, F., Krystal, G. Humphries, R.K. (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes and Development, 12, 1610 1620. (Pubitemid 28299513)
33. Hensold, J.O., Dubyak, G. Housman, D.E. (1991) Calcium ionophore, A23187, induces commitment to differentiation but inhibits the subsequent expression of erythroid genes in murine erythroleukemia cells. Blood, 77, 1362 1370.
34. Hirschler-Laszkiewicz, I., Tong, Q., Conrad, K., Zhang, W., Flint, W.W., Barber, A.J., Barber, D.L., Cheung, J.Y. Miller, B.A. (2009) TRPC3 activation by erythropoietin is modulated by TRPC6. Journal of Biological Chemistry, 284, 4567 4581.
35. Hortner, M., Nielsch, U., Mayr, L.M., Heinrich, P.C. Haan, S. (2002) A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. European Journal of Biochemistry, 269, 2516 2526.
36. Hoyer, J.D., Allen, S.L., Beutler, E., Kubik, K., West, C. Fairbanks, V.F. (2004) Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. American Journal of Hematology, 75, 205 208.
37. Huang, L.J., Constantinescu, S.N. Lodish, H.F. (2001) The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Molecular Cell, 8, 1327 1338.
38. Ingley, E., McCarthy, D.J., Pore, J.R., Sarna, M.K., Adenan, A.S., Wright, M.J., Erber, W., Tilbrook, P.A. Klinken, S.P. (2005) Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis. Oncogene, 24, 336 343.
39. Juvonen, E., Ikkala, E., Fyhrquist, F. Ruutu, T. (1991) Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood, 78, 3066 3069.
40. Karur, V.G., Lowell, C.A., Besmer, P., Agosti, V. Wojchowski, D.M. (2006) Lyn kinase promotes erythroblast expansion and late-stage development. Blood, 108, 1524 1532.
41. Kashii, Y., Uchida, M., Kirito, K., Tanaka, M., Nishijima, K., Toshima, M., Ando, T., Koizumi, K., Endoh, T., Sawada, K., Momoi, M., Miura, Y., Ozawa, K. Komatsu, N. (2000) A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood, 96, 941 949.
42. Klingmuller, U., Lorenz, U., Cantley, L.C., Neel, B.G. Lodish, H.F. (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell, 80, 729 738.
43. Klingmuller, U., Bergelson, S., Hsiao, J.G. Lodish, H.F. (1996) Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proceedings of the National Academy of Sciences of the United States of America, 93, 8324 8328.
44. Klingmuller, U., Wu, H., Hsiao, J.G., Toker, A., Duckworth, B.C., Cantley, L.C. Lodish, H.F. (1997) Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proceedings of the National Academy of Sciences of the United States of America, 94, 3016 3021.
45. Kralovics, R. Prchal, J.T. (2001) Genetic heterogeneity of primary familial and congenital polycythemia. American Journal of Hematology, 68, 115 121.
46. Kralovics, R., Indrak, K., Stopka, T., Berman, B.W., Prchal, J.F. Prchal, J.T. (1997a) Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood, 90, 2057 2061.
47. Kralovics, R., Sokol, L., Broxson, Jr., E.H. Prchal, J.T. (1997b) The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia. Proceedings of the Association of American Physicians, 109, 580 585.
48. Kralovics, R., Sokol, L. Prchal, J.T. (1998) Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. Journal of Clinical Investigation, 102, 124 129.
49. Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouyssegur, J., Richard, S. Gardie, B. (2008) PHD2 mutation and congenital erythrocytosis with paraganglioma. New England Journal of Medicine, 359, 2685 2692.
50. Le Couedic, J.P., Mitjavila, M.T., Villeval, J.L., Feger, F., Gobert, S., Mayeux, P., Casadevall, N. Vainchenker, W. (1996) Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood, 87, 1502 1511.
51. Levin, I., Cohen, J., Supino-Rosin, L., Yoshimura, A., Watowich, S.S. Neumann, D. (1998) Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization. FEBS Letters, 427, 164 170.
52. Levine, R.L. Gilliland, D.G. (2008) Myeloproliferative disorders. Blood, 112, 2190 2198.
53. Martini, M., Teofili, L., Cenci, T., Giona, F., Torti, L., Rea, M., Foa, R., Leone, G. Larocca, L.M. (2008) A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. Haematologica, 93, 1068 1071.
54. Mason, J.M., Beattie, B.K., Liu, Q., Dumont, D.J. Barber, D.L. (2000) The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor. Journal of Biological Chemistry, 275, 4398 4406.
55. Means, R.T. Jr. (2004) Erythrocytosis. In : Wintrobe's Clinical Hematology (ed. by J.N. Leukens, J.P. Greer, J. Foerster, G.M. Rodgers, F. Paraskevas B. Glader pp. 1495 1508, 11th edn. Lippincott Williams & Wilkins, Philadelphia.
56. Menon, M.P., Fang, J. Wojchowski, D.M. (2006a) Core erythropoietin receptor signals for late erythroblast development. Blood, 107, 2662 2672.
57. Menon, M.P., Karur, V., Bogacheva, O., Bogachev, O., Cuetara, B. Wojchowski, D.M. (2006b) Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. Journal of Clinical Investigation, 116, 683 694.
58. Meyer, L., Deau, B., Forejtnikova, H., Dumenil, D., Margottin-Goguet, F., Lacombe, C., Mayeux, P. Verdier, F. (2007) beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood, 109, 5215 5222.
59. Neubauer, H., Cumano, A., Muller, M., Wu, H., Huffstadt, U. Pfeffer, K. (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell, 93, 397 409.
60. Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.C., Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen, J.M., Grosveld, G. Ihle, J.N. (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93, 385 395.
61. Patnaik, M.M. Tefferi, A. (2009) The complete evaluation of erythrocytosis: congenital and acquired. Leukemia, 23, 834 844.
62. Percy, M.J., McMullin, M.F., Roques, A.W., Westwood, N.B., Acharya, J., Hughes, A.E., Lappin, T.R. Pearson, T.C. (1998) Erythrocytosis due to a mutation in the erythropoietin receptor gene. British Journal of Haematology, 100, 407 410.
63. Percy, M.J., Zhao, Q., Flores, A., Harrison, C., Lappin, T.R., Maxwell, P.H., McMullin, M.F. Lee, F.S. (2006) A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 103, 654 659.
64. Percy, M.J., Furlow, P.W., Beer, P.A., Lappin, T.R., McMullin, M.F. Lee, F.S. (2007) A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood, 110, 2193 2196.
65. Percy, M.J., Furlow, P.W., Lucas, G.S., Li, X., Lappin, T.R., McMullin, M.F. Lee, F.S. (2008) A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. New England Journal of Medicine, 358, 162 168.
66. Petersen, K.B., Hokland, P., Petersen, G.B. Nyvold, C.G. (2004) Erythropoietin receptor defect: a cause of primary polycythaemia. British Journal of Haematology, 125, 537 538.
67. Petroski, M.D. Deshaies, R.J. (2005) Function and regulation of cullin-RING ubiquitin ligases. Nature Reviews. Molecular Cell Biology, 6, 9 20.
68. Prchal, J.T. (2001) Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. Seminars in Hematology, 38, 10 20.
69. Prchal, J.T. (2005) Polycythemia vera and other primary polycythemias. Current Opinion in Hematology, 12, 112 116.
70. Prchal, J.T., Crist, W.M., Goldwasser, E., Perrine, G. Prchal, J.F. (1985) Autosomal dominant polycythemia. Blood, 66, 1208 1214.
71. Prchal, J.T., Semenza, G.L., Prchal, J. Sokol, L. (1995) Familial polycythemia. Science, 268, 1831 1832.
72. Queisser, W., Heim, M.E., Schmitz, J.M. Worst, P. (1988) [Idiopathic familial erythrocytosis. Report on a family with autosomal dominant inheritance]. Deutsche Medizinische Wochenschrift, 113, 851 856.
73. Richmond, T.D., Chohan, M. Barber, D.L. (2005) Turning cells red: signal transduction mediated by erythropoietin. Trends in Cell Biology, 15, 146 155.
74. Rives, S., Pahl, H.L., Florensa, L., Bellosillo, B., Neusuess, A., Estella, J., Debatin, K.M., Kohne, E., Schwarz, K. Cario, H. (2007) Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis. Haematologica, 92, 674 677.
75. Rumi, E., Passamonti, F., Pagano, L., Ammirabile, M., Arcaini, L., Elena, C., Flagiello, A., Tedesco, R., Vercellati, C., Marcello, A.P., Pietra, D., Moratti, R., Cazzola, M. Lazzarino, M. (2009) Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. Journal of Internal Medicine, 265, 266 274.
76. Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J.A. Yoshimura, A. (1999) Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells, 4, 339 351.
77. Sigismund, S., Woelk, T., Puri, C., Maspero, E., Tacchetti, C., Transidico, P., Di Fiore, P.P. Polo, S. (2005) Clathrin-independent endocytosis of ubiquitinated cargos. Proceedings of the National Academy of Sciences of the United States of America, 102, 2760 2765.
78. Skoda, R. Prchal, J.T. (2005) Lessons from familial myeloproliferative disorders. Seminars in Hematology, 42, 266 273.
79. Socolovsky, M., Fallon, A.E., Wang, S., Brugnara, C. Lodish, H.F. (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell, 98, 181 191.
80. Sokol, L., Prchal, J.F., D'Andrea, A., Rado, T.A. Prchal, J.T. (1994) Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Experimental Hematology, 22, 447 453.
81. Sokol, L., Luhovy, M., Guan, Y., Prchal, J.F., Semenza, G.L. Prchal, J.T. (1995) Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood, 86, 15 22.
82. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A. Hilton, D.J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature, 387, 917 921.
83. Sulahian, R., Cleaver, O. Huang, L.J. (2009) Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Blood, 113, 5287 5297.
84. Suzuki, N., Ohneda, O., Takahashi, S., Higuchi, M., Mukai, H.Y., Nakahata, T., Imagawa, S. Yamamoto, M. (2002) Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood, 100, 2279 2288.
85. Tauchi, T., Damen, J.E., Toyama, K., Feng, G.S., Broxmeyer, H.E. Krystal, G. (1996) Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood, 87, 4495 4501.
86. Tilbrook, P.A., Palmer, G.A., Bittorf, T., McCarthy, D.J., Wright, M.J., Sarna, M.K., Linnekin, D., Cull, V.S., Williams, J.H., Ingley, E., Schneider-Mergener, J., Krystal, G. Klinken, S.P. (2001) Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn. Cancer Research, 61, 2453 2458.
87. Tong, W., Zhang, J. Lodish, H.F. (2005) Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood, 105, 4604 4612.
88. Vainchenker, W., Dusa, A. Constantinescu, S.N. (2008) JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. Seminars in Cell & Developmental Biology, 19, 385 393.
89. Van Maerken, T., Hunninck, K., Callewaert, L., Benoit, Y., Laureys, G. Verlooy, J. (2004) Familial and congenital polycythemias: a diagnostic approach. Journal of Pediatric Hematology/Oncology, 26, 407 416.
90. Van Zant, G. Shultz, L. (1989) Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Experimental Hematology, 17, 81 87.
91. Verdier, F., Chretien, S., Muller, O., Varlet, P., Yoshimura, A., Gisselbrecht, S., Lacombe, C. Mayeux, P. (1998) Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. Journal of Biological Chemistry, 273, 28185 28190.
92. Walrafen, P., Verdier, F., Kadri, Z., Chretien, S., Lacombe, C. Mayeux, P. (2005) Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood, 105, 600 608.
93. Watowich, S.S., Xie, X., Klingmuller, U., Kere, J., Lindlof, M., Berglund, S. de la Chapelle, A. (1999) Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state. Blood, 94, 2530 2532.
94. Wojchowski, D.M., Menon, M.P., Sathyanarayana, P., Fang, J., Karur, V., Houde, E., Kapelle, W. Bogachev, O. (2006) Erythropoietin-dependent erythropoiesis: new insights and questions. Blood Cells, Molecules, and Diseases, 36, 232 238.
95. Wormald, S. Hilton, D.J. (2004) Inhibitors of cytokine signal transduction. Journal of Biological Chemistry, 279, 821 824.
96. Wu, H., Liu, X., Jaenisch, R. Lodish, H.F. (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell, 83, 59 67.
97. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N. Yoshimura, A. (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO Journal, 18, 1309 1320.
98. Yi, T., Zhang, J., Miura, O. Ihle, J.N. (1995) Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood, 85, 87 95.
99. Yilmaz, D., Cogulu, O., Ozkinay, F., Kavakli, K. Roos, D. (2005) A novel mutation in the DIA1 gene in a patient with methemoglobinemia type II. American Journal of Medical Genetics Part A, 133A, 101 102.
100. Zang, H., Sato, K., Nakajima, H., McKay, C., Ney, P.A. Ihle, J.N. (2001) The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO Journal, 20, 3156 3166.
101. Zhao, W., Kitidis, C., Fleming, M.D., Lodish, H.F. Ghaffari, S. (2006) Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood, 107, 907 915.